Permax and Dostinex, two drugs used to treat Parkinson’s disease have been linked to serious heart valve damage. Pergolide, sold as Permax, has carried a black box warning from the FDA since 2006. The warning includes the following: ”Some patients have required valve replacement, and deaths have been reported.”
A milder warning was issued for Dostinex just last month.